Lindsey Rolfe
2021
In 2021, Lindsey Rolfe earned a total compensation of $1.2M as EVP of Clinical Development and Pharmacovigilance and Chief Medical Officer at Clovis Oncology, a 10% decrease compared to previous year.
Compensation breakdown
| Bonus | $201,867 |
|---|---|
| Salary | $535,630 |
| Stock Awards | $504,630 |
| Total | $1,242,127 |
Rolfe received $535.6K in salary, accounting for 43% of the total pay in 2021.
Rolfe also received $201.9K in bonus and $504.6K in stock awards.
Rankings
In 2021, Lindsey Rolfe's compensation ranked 7,992nd out of 12,415 executives tracked by ExecPay. In other words, Rolfe earned more than 35.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,992 out of 12,415 | 36th |
Division Manufacturing | 3,532 out of 5,508 | 36th |
Major group Chemicals And Allied Products | 1,569 out of 2,378 | 34th |
Industry group Drugs | 1,394 out of 2,099 | 34th |
Industry Pharmaceutical Preparations | 1,034 out of 1,549 | 33rd |
Pay ratio
| Lindsey Rolfe's Pay | $1,242,127 |
|---|---|
| Median Employee's Pay | $246,936 |
| Pay Ratio | 5to 1 |
In 2021, the annual total compensation of Lindsey Rolfe was $1,242,127.
The annual total compensation of the median employee at Clovis Oncology was $246,936.
The ratio of Lindsey Rolfe's pay to the pay of median employee was therefore 5 to one.
Source: SEC filing on April 27, 2022.
Rolfe's colleagues
We found four more compensation records of executives who worked with Lindsey Rolfe at Clovis Oncology in 2021.
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019